Literature DB >> 7510677

Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts.

J Chen1, S Parsons, D L Brautigan.   

Abstract

The catalytic subunit of protein phosphatase 2A (PP2A) is inactivated by in vitro phosphorylation of Tyr307 by receptor and nonreceptor protein tyrosine kinases (Chen, J., Martin, B. L., and Brautigan, D. L. (1992) Science 257, 1261-1264). Here we show the phosphorylation of PP2A in cells under different growth conditions. In lysates of nontransformed murine 10T1/2 fibroblasts, there were two forms of PP2A at 36 kDa detected after two-dimensional gel electrophoresis and immunoblotting with anti-PP2A peptide antibody. These two forms exactly comigrated with unphosphorylated purified PP2A and the PP2A 32P-labeled by in vitro phosphorylation with p60v-src kinase. The phosphorylated form of PP2A recovered from red blood cells or produced by in vitro phosphorylation was eliminated by incubation with tyrosine-specific phosphatase (PTP1B). Transformation of 10T1/2 cells by expression of p60v-src resulted in most of the PP2A in the cells being converted to a phosphorylated form that was reactive with anti-phosphotyrosine antibody. Serum starvation of cells reduced the amount of phosphorylated PP2A, whereas serum stimulation of quiescent cells caused an increase to the same relative amount of phosphorylated PP2A as in src-transformed cells. Addition of epidermal growth factor to quiescent NeoR cells (10T1/2 fibroblasts overexpressing epidermal growth factor receptors) temporarily increased the level of phosphorylation of PP2A, with a peak at 5-15 min and a return to basal level within 60 min. The results show that PP2A is phosphorylated in intact cells, and the extent of this modification is increased by growth factors or cell transformation, providing evidence for a physiological mechanism of PP2A regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510677

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Protein kinases as therapeutic targets.

Authors:  R Sridhar; O Hanson-Painton; D R Cooper
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits.

Authors:  T Tolstykh; J Lee; S Vafai; J B Stock
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

3.  Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells.

Authors:  Charles S T Hii; Maurizio Costabile; George C Mayne; Channing J Der; Andrew W Murray; Antonio Ferrante
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

4.  Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells.

Authors:  G Vani; C S Shyamala Devi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

5.  Subunit composition and developmental regulation of hepatic protein phosphatase 2A (PP2A).

Authors:  Sunny J-S Yoo; Joan M Boylan; David L Brautigan; Philip A Gruppuso
Journal:  Arch Biochem Biophys       Date:  2007-03-07       Impact factor: 4.013

6.  PP2A: a new link between peroxynitrite and endothelial barrier dysfunction?

Authors:  Qin Wang
Journal:  Cardiovasc Res       Date:  2008-11-11       Impact factor: 10.787

7.  Inhibition of Ser/Thr phosphatases induces capacitation-associated signaling in the presence of Src kinase inhibitors.

Authors:  Dario Krapf; Enid Arcelay; Eva V Wertheimer; Archana Sanjay; Stephen H Pilder; Ana M Salicioni; Pablo E Visconti
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

8.  A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.

Authors:  Kyoungja Hong; Liguang Lou; Sandhya Gupta; Fernando Ribeiro-Neto; Daniel L Altschuler
Journal:  J Biol Chem       Date:  2008-06-12       Impact factor: 5.157

9.  Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A.

Authors:  I Griswold-Prenner; C Kamibayashi; E M Maruoka; M C Mumby; R Derynck
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

10.  Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A.

Authors:  M Campbell; P Anderson; E R Trimble
Journal:  Diabetologia       Date:  2008-03-14       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.